STK11 and endometrial cancer: Contreras et al. showed that the inactivation of Serine/threonine kinase 11 (LKB1)—a master regulator of the Adenosine monophosphate-activated protein kinase (AMPK)-mTOR signaling—is sufficient to drive endometrial cancer development [109].